Predict your next investment

HEALTHCARE | Medical Facilities & Services

See what CB Insights has to offer

Founded Year



Unattributed VC - V | Alive

Total Raised


Last Raised

$1.57M | 17 yrs ago

About QMed

QMed is a Healthcare/Medical Facilities & Services company based in Eatontown, New Jersey. QMed's investors include Downsview Capital, Omicron Capital, Highbridge Capital Management and Iroquois Capital.

QMed Headquarter Location

25 Christopher Way

Eatontown, New Jersey, 07724,

United States


Latest QMed News

10:20 ET QMed Innovations Announces Series A Investment Led by RJ Valentine and The MBA Group

Sep 7, 2021

New Partnership Focused on Growth to Address Orthopedic Customer Needs for Emerging Technology in Asset Tracking News provided by Share this article Share this article MIDDLETOWN, R.I., Sept. 7, 2021 /PRNewswire/ --  QMed Innovations , creator of unique hardware and software asset tracking systems for the medical device industry, today announced that RJ Valentine Ventures/ The MBA Group  has led Series A financing to accelerate growth. This round of funding is now successfully closed. The investment will enable QMed Innovations to continue momentum that began in 2019 and has accelerated in 2021. Today, over a dozen leading medical device manufacturers use QMed Innovations' products— Quest and Quest Tote —to track the daily location of inventory to maximize capital investment. QMed products are fully autonomous Internet of Things (IoT) tracking solutions and Quest is the first asset tracking solution that can withstand the high temperatures and pressures of the autoclave sterilization process, essential for the medical device industry. "We are thrilled to partner with the QMed Innovations team to help lead a new chapter in the organization's growth," said Valentine, Chairman, RJ Valentine Ventures/The MBA Group. "We see a large market opportunity in asset tracking. QMed products are designed with emerging technology that can give customers unprecedented, powerful data for asset tracking and strategic inventory cost management." Gartner , the world's leading research and advisory company, offers a supporting perspective on the asset tracking market opportunity. Its recent "Emerging Technologies: Revenue Opportunity Projection of Indoor Location Services" projected asset tracking to grow from less than $1 billion in 2021 to nearly $26 billion by 2030. The report expects asset tracking to reach early majority adoption by 2026 when it will reach a market volume of $6.7 billion. "QMed Innovations is revolutionizing the way medical device manufacturers, distributors, and providers can track their instruments," said Victor Nunes, QMed Innovations Founder and CEO. "We are excited to partner with RJ Valentine and The MBA Group to expand our go-to-market strategies, drive adoption, and provide our customers with return on investment based on critical time saved and reduced costs—improving their bottom line performance." About QMed Innovations QMed Innovations enables medical device manufacturers, distributors, and providers to better track their instruments by providing unique hardware and software solutions that automatically deliver data and analytics for unprecedented insight. Learn more at . Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.